BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33170578)

  • 1. Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    Nichols BE; Cele R; Jamieson L; Long LC; Siwale Z; Banda P; Moyo C; Rosen S
    AIDS; 2021 Feb; 35(2):299-306. PubMed ID: 33170578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis.
    Jo Y; Rosen S; Sy KTL; Phiri B; Huber AN; Mwansa M; Shakwelele H; Haimbe P; Mwenechanya MM; Lumano-Mulenga P; Nichols BE
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25808. PubMed ID: 34713620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based differentiated service delivery models incorporating multi-month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster-randomized trials in southern Africa.
    Fatti G; Ngorima-Mabhena N; Tiam A; Tukei BB; Kasu T; Muzenda T; Maile K; Lombard C; Chasela C; Grimwood A
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25819. PubMed ID: 34713614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia.
    Jo Y; Jamieson L; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Mulenga PL; Nichols BE; Rosen S
    PLoS One; 2023; 18(3):e0280748. PubMed ID: 36917568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia.
    Jamieson L; Rosen S; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Lumano-Mulenga P; Chiboma I; Nichols BE
    BMJ Open; 2022 Dec; 12(12):e064070. PubMed ID: 36549722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
    Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
    J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.
    Long L; Kuchukhidze S; Pascoe S; Nichols BE; Fox MP; Cele R; Govathson C; Huber AN; Flynn D; Rosen S
    J Int AIDS Soc; 2020 Nov; 23(11):e25640. PubMed ID: 33247517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019.
    Rosen S; Nichols B; Guthrie T; Benade M; Kuchukhidze S; Long L
    Gates Open Res; 2021; 5():177. PubMed ID: 35310814
    [No Abstract]   [Full Text] [Related]  

  • 9. The SENTINEL study of differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: research protocol for a prospective cohort study.
    Pascoe S; Huber A; Mokhele I; Lekodeba N; Ntjikelane V; Sande L; Tchereni T; Haimbe P; ; Rosen S
    BMC Health Serv Res; 2023 Aug; 23(1):891. PubMed ID: 37612720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey.
    Mokhele I; Huber A; Rosen S; Kaiser JL; Lekodeba N; Ntjikelane V; Hendrickson C; Scott N; Pascoe S
    J Int AIDS Soc; 2024 Mar; 27(3):e26233. PubMed ID: 38528370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
    Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client and provider preferences for HIV care: Implications for implementing differentiated service delivery in Thailand.
    Lujintanon S; Amatavete S; Sungsing T; Seekaew P; Peelay J; Mingkwanrungruang P; Chinbunchorn T; Teeratakulpisarn S; Methajittiphan P; Leenasirima P; Norchaiwong A; Nilmanat A; Phanuphak P; Ramautarsing RA; Phanuphak N
    J Int AIDS Soc; 2021 Apr; 24(4):e25693. PubMed ID: 33792192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysis.
    Bolton-Moore C; Sikazwe I; Mubiana-Mbewe M; Munthali G; Wa Mwanza M; Savory T; Nkhoma L; Somwe P; Namwase AS; Geng EH; Mody A
    Lancet HIV; 2022 Aug; 9(8):e563-e573. PubMed ID: 35905754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.
    Hoffman RM; Balakasi K; Bardon AR; Siwale Z; Hubbard J; Kakwesa G; Haambokoma M; Kalua T; Pisa P; Moyo C; Dovel K; Xulu T; Sanne I; Fox M; Rosen S
    AIDS; 2020 Mar; 34(3):475-479. PubMed ID: 31764076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "We are part of a family". Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study.
    Pellecchia U; Baert S; Nundwe S; Bwanali A; Zamadenga B; Metcalf CA; Bygrave H; Daho S; Ohler L; Chibwandira B; Kanyimbo K
    J Int AIDS Soc; 2017 Mar; 20(1):21374. PubMed ID: 28406273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals.
    Prust ML; Banda CK; Nyirenda R; Chimbwandira F; Kalua T; Jahn A; Eliya M; Callahan K; Ehrenkranz P; Prescott MR; McCarthy EA; Tagar E; Gunda A
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21650. PubMed ID: 28770594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia.
    Scott CA; Iyer HS; Lembela Bwalya D; Bweupe M; Rosen SB; Scott N; Larson BA
    PLoS One; 2013; 8(8):e72444. PubMed ID: 24015245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment.
    Eshun-Wilson I; Mukumbwa-Mwenechanya M; Kim HY; Zannolini A; Mwamba CP; Dowdy D; Kalunkumya E; Lumpa M; Beres LK; Roy M; Sharma A; Topp SM; Glidden DV; Padian N; Ehrenkranz P; Sikazwe I; Holmes CB; Bolton-Moore C; Geng EH
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):540-546. PubMed ID: 31021988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.